Geo News
Community curated by people like you
LatestAICryptoHealthWorld AffairsUS Politics
←Back to story

FDA OKs First Drug to Reduce Mortality in Rare Niemann-Pick Disease Type C

MedscapeView source article

Part of story

FDA approves adrabetadex for Niemann-Pick disease type C

The FDA approved adrabetadex for Niemann-Pick disease type C, a rare fatal genetic disorder, after treated patients showed longer survival compared to external controls.

Nov 18, 2026·2 sourcesDrug safetyDrug Policy, Pricing & ApprovalGenetic disordersNeurodegenerative diseaseRare diseasesFDA drug approvalIntrathecalOrphan drug designation
FDA approves adrabetadex for Niemann-Pick disease type C
00

Other sources for this story

MedPage Today

FDA OKs Drug Linked to Longer Survival in Fatal Genetic Disorder